Literature DB >> 1270130

Responses of mice immunized with influenza virus by serosol and parenteral routes.

G H Scott, R J Sydiskis.   

Abstract

Antibody levels in sera and respiratory secretions and resistance to respiratory infections were examined in mice given live infuenza virus in small-particle (2 mum) aerosols, large-particle (10 mum) aerosols, intraperitoneally, and subcutaneously. After parenteral administration antibody was found primarily in the serum, but small amounts were recovered in bronchoalveolar washings after 2 to 3 weeks. Specific antibody was present in both sera and bronchoalveolar washings from mice given virus in small-particle aerosols to achieve virus dissemination throughout the respiratory tract. Immunoglobulin A, immunoglobulin G, and trace amounts of immunoglobulin M, all specific for the infecting virus, were detected in bronchoalveolar washings of small-particle aerosol-infected mice. Virus administration in large-particle aerosols (for primary virus localization in upper respiratory tract) at doses greater than those required to initiate infection with small-particle aerosols failed to stimulate production of antibody in sera or bronchoalveolar washings. Small-particle aerosol-immunized mice were resistant to subsequent challenge with 10(2.0) respiratory median lethal doses of virulent virus, whereas large-particle aerosol-immunized mice were not protected. Parenteral immunization modified the course of the disease in challenged mice and reduce mortality rates but did not prevent reinfection of the respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1270130      PMCID: PMC420666          DOI: 10.1128/iai.13.3.696-703.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  SINGLE-STAGE IMPACTION DEVICE FOR PARTICLE SIZING BIOLOGICAL AEROSOLS.

Authors:  J E MALLIGO; L S IDOINE
Journal:  Appl Microbiol       Date:  1964-01

2.  An apparatus for the study of airborne infection.

Authors:  D W HENDERSON
Journal:  J Hyg (Lond)       Date:  1952-03

3.  Studies in experimental immunology of influenza. IV. The protective value of active immunization.

Authors:  S FAZEKAS de ST GROTH; M DONNELLEY
Journal:  Aust J Exp Biol Med Sci       Date:  1950-01

4.  Studies in experimental immunology of influenza. III. The antibody response.

Authors:  S FAZEKAS de ST GROTH; M DONNELLEY
Journal:  Aust J Exp Biol Med Sci       Date:  1950-01

5.  Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines.

Authors:  C B Smith; J A Bellanti; R M Chanock
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

6.  The sedimentation behavior of rhinovirus neutralizing activity in nasal secretion and serum following the rhinovirus common cold.

Authors:  R D Rossen; G Douglas; T R Cate; R B Couch; W T Butler
Journal:  J Immunol       Date:  1966-10       Impact factor: 5.422

7.  Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization.

Authors:  C A Phillips; B R Forsyth; W A Christmas; D W Gump; E B Whorton; I Rogers; A Rudin
Journal:  J Infect Dis       Date:  1970 Jul-Aug       Impact factor: 5.226

8.  Spinning-top homogeneous aerosol generator with shockproof mounting.

Authors:  K R May
Journal:  J Sci Instrum       Date:  1966-11

9.  immunoglobulin and histamine-sensitivity response of mice to live Bordetella pertussis.

Authors:  B D Geller; M Pittman
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

10.  An evaluation of influenza immunization: influence of route of administration and vaccine strain.

Authors:  R H Waldman; J O Bond; L P Levitt; E C Hartwig; E C Prather; R L Baratta; J S Neill; P A Small
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

View more
  10 in total

1.  Aerosol inoculation with a sub-lethal influenza virus leads to exacerbated morbidity and pulmonary disease pathogenesis.

Authors:  Jennifer Humberd Smith; Tamas Nagy; Jamie Barber; Paula Brooks; S Mark Tompkins; Ralph A Tripp
Journal:  Viral Immunol       Date:  2011-04       Impact factor: 2.257

2.  Dynamics of B-lymphocytes in the lungs of mice exposed to aerosolized influenza virus.

Authors:  S L Owens; J W Osebold; Y C Zee
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

3.  Antibody responses and interferon titers in the respiratory tracts of mice after aerosolized exposure to influenza virus.

Authors:  Y C Zee; J W Osebold; W M Dotson
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

4.  Immunoglobulin class-specific antibody response in serum, spleen, lungs, and bronchoalveolar washings after primary and secondary sendai virus infection of germfree mice.

Authors:  D Charlton; G Blandford
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

5.  Therapeutic effects of ribavirin given by the intraperitoneal or aerosol route against influenza virus infections in mice.

Authors:  E L Stephen; J W Dominik; J B Moe; J S Walker
Journal:  Antimicrob Agents Chemother       Date:  1976-09       Impact factor: 5.191

6.  Active synthesis of hemagglutinin-specific immunoglobulin A by lung cells of mice that were immunized intragastrically with inactivated influenza virus vaccine.

Authors:  K S Chen; D B Burlington; G V Quinnan
Journal:  J Virol       Date:  1987-07       Impact factor: 5.103

7.  Oral immunization of rats with proteinoid microspheres encapsulating influenza virus antigens.

Authors:  N Santiago; S Milstein; T Rivera; E Garcia; T Zaidi; H Hong; D Bucher
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

8.  Activity of amantadine, rimantadine, and ribavirin against swine influenza in mice and squirrel monkeys.

Authors:  G H Scott; E L Stephen; R F Berendt
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

9.  Comparison of the effectiveness of antibody and cell-mediated immunity against inhaled and instilled influenza virus challenge.

Authors:  Katie Rivers; Larry E Bowen; Jin Gao; Kevin Yang; John E Trombley; J Kyle Bohannon; Maryna C Eichelberger
Journal:  Virol J       Date:  2013-06-19       Impact factor: 4.099

10.  [Aerosol vaccination of mice with inactivated influenza virus (author's transl)].

Authors:  M Neukirch; K Bauer
Journal:  Zentralbl Bakteriol A       Date:  1980-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.